![virtual town hall](https://reproductiverights.org/wp-content/uploads/2023/06/DobbsAnni_LandingPage_TownHall-04-1-750x422.png)
Join us! Virtual Town Hall on U.S. Abortion Rights: Thursday, June 20
Join us for a virtual town hall Thursday, June 20!
Join us for a virtual town hall Thursday, June 20!
Court rules that anti-abortion plaintiffs suing the FDA do not have standing, leaving the widely used abortion drug accessible through telemedicine and pharmacies—for now.
Current regulations of mifepristone will remain unchanged for now
Lima. 13 de junio de 2024. (PRONUNCIAMIENTO) – Con profunda preocupación, DEMUS estudio para la defensa de los derechos de la mujer, el Centro de Derechos Reproductivos, y el Centro por la Justicia y el Derecho Internacional (CEJIL), en calidad de organizaciones defensoras de derechos humanos y representantes de Celia Ramos y familiares ante la […]
“Frankly, this ruling feels like a gut punch, not just for pregnant Texans but also for doctors in our state.” —Lead plaintiff Amanda Zurawski
Recent comments submitted by the Center’s U.S. Federal Policy and Advocacy team on proposed rules and regulations impacting reproductive health and rights.
In Zurawski v. State of Texas, court refuses to provide clarity on exceptions to state abortion bans.
5.31.2024 (PRESS RELEASE) – Today, the Texas Supreme Court issued a ruling in Zurawski v. Texas that fails to provide any meaningful clarity on when doctors can perform abortions for dire medical reasons. The ruling largely ignores the women who filed the case, writing them out of the opinion. The Court stated definitively that people […]